In contrast, Dovedi et al demonstrated that PD‐L1 inhibition in combination with lower RT doses (5 × 2 Gy) was sufficient to delay tumor growth in colorectal and triple‐negative breast cancers (Dovedi et al, 2014). The gene discussed is CD274; the disease is neoplasm.